ID   Karpas-160
AC   CVCL_QZ00
SY   Karpas 160; K160
DR   Wikidata; Q54899484
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   PubMed=300025;
RX   PubMed=412508;
RX   PubMed=1591220;
RX   PubMed=2784005;
CC   Characteristics: Highly cytotoxic (PubMed=300025).
CC   Characteristics: Produces lymphotoxin-alpha (PubMed=2784005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1007/978-1-4613-2823-0_29;
RA   Karpas A.;
RT   "Viruses and human leukemia in vitro.";
RL   (In book chapter) Human leukemia. Cytochemical and ultrastructural techniques in diagnosis and research. Developments in Oncology, Vol. 14; Polliack A. (eds.); pp.495-526; Martinus Nijhoff Publishing; Boston; USA (1984).
//
RX   PubMed=300025; DOI=10.1038/bjc.1977.22; PMCID=PMC2025323;
RA   Karpas A.;
RT   "A human haemic cell line capable of cellular and humoral killing of
RT   normal and malignant cells.";
RL   Br. J. Cancer 35:152-160(1977).
//
RX   PubMed=412508; DOI=10.1038/bjc.1977.212; PMCID=PMC2025377;
RA   Karpas A.;
RT   "A humoral cytotoxic substance produced by a human killer cell line.";
RL   Br. J. Cancer 36:437-445(1977).
//
RX   PubMed=1591220; DOI=10.1093/intimm/4.4.519;
RA   Ni J., Meager A., Karpas A.;
RT   "Characterization and partial purification of a novel cytotoxic
RT   lymphokine (factor 2) produced by a human B cell line (Karpas 160).";
RL   Int. Immunol. 4:519-531(1992).
//
RX   PubMed=2784005; DOI=10.1073/pnas.86.4.1343; PMCID=PMC286686;
RA   Yamanaka H.I., Karpas A.;
RT   "Identity of human B-cell line cytotoxic lymphokine with tumor
RT   necrosis factor type beta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1343-1347(1989).
//